Costs of diabetes mellitus in Korea
- PMID: 22247897
- PMCID: PMC3253965
- DOI: 10.4093/dmj.2011.35.6.567
Costs of diabetes mellitus in Korea
Abstract
Outcome research focusing on the economics of the medical field began in the mid-1990s and has included studies about costs, cost effectiveness, and policies. According to the American Diabetes Association, the total estimated cost of diabetes in 2007 was $174 billion. The economic burden of patients with diabetes in Canada is expected to be about $12.2 billion in 2010. Recent Korean studies have analyzed the expenses associated with type 2 diabetes for patients in selected general hospitals. Type 2 diabetic patients without complications cost approximately 1,184,563 won (the equivalent of US $1,184) per patient for healthcare annually. In contrast, patients with microvascular disease due to diabetic complications cost up to 4.7 times that amount, and patients with macrovascular disease incur up to 10.7 times the annual costs for patients without diabetic complications. Diabetic complications ultimately impact the quality of life for patients and patient mortality, and are associated with higher direct medical expenses for patients. To avoid increased medical costs, appropriate management techniques must be implemented to ensure timely care for patients with diabetes.
Keywords: Diabetes mellitus; Outcome research.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
References
-
- Gan D International Diabetes Federation; World Diabetes Foundation. Diabetes atlas. 2nd ed. Brussels: International Diabetes Federation; 2003. pp. 15–71.
-
- Bjork S. The cost of diabetes and diabetes care. Diabetes Res Clin Pract. 2001;54(Suppl 1):S13–S18. - PubMed
-
- Kim KS, Choi CH, Lee DY, Kim EJ. Epidemiological study on diabetes mellitus among rural Korean. J Korean Diabetes Assoc. 1972;1:17–24.
-
- Korea Centers for Disease Control and Prevention. The Third Korea National Health and Nutrition Examination Survey (KNHANES III), 2005: illness of adults. Seoul: Korea Centers for Disease Control and Prevention; 2006.
-
- Annemans L. Pharmacoeconomics for decision makers; Paper presented at: ISPOR 10th Annual European Congress; 2007 Oct 20-23; Dublin, IE.
LinkOut - more resources
Full Text Sources